000			02155cam a2200349 4500500
005			20260111052915.0
041			_afre
042			_adc
100	1	0	_aMacher, Marie-Alice _eauthor
700	1	0	_aMongi Bacha, Mohamed _eauthor
700	1	0	_aSoualmia, Amel _eauthor
700	1	0	_aLaouad, Inass _eauthor
700	1	0	_aSfar, Imen _eauthor
700	1	0	_aJacquelinet, Christian _eauthor
700	1	0	_aMeçabih, Fateh _eauthor
700	1	0	_aYounous, Said _eauthor
700	1	0	_aBayar, Rached _eauthor
700	1	0	_aZiadi, Jalel _eauthor
700	1	0	_aEl Kader Nebab, Abed _eauthor
700	1	0	_aBarry, Naïma _eauthor
700	1	0	_aNouvellon, Hélène _eauthor
700	1	0	_aGozzerino, Agathe _eauthor
700	1	0	_aDurin, Laurent _eauthor
700	1	0	_aBen Abdallah, Taieb _eauthor
700	1	0	_aTsimaratos, Michel _eauthor
245	0	0	_aAccess to kidney transplantation for patients with end-stage renal failure in the Maghreb countries: State of the art and recommendations
260			_c2024.
500			_a66
520			_aWe present an overview of kidney transplantation activity in the Maghreb countries, based on data from the 9th France-Maghreb Symposium (Paris, May 20 and 21, 2022). For Algeria, Morocco, and Tunisia, the incidence of end-stage renal failure is 120, 130, and 130 per million inhabitants, respectively. Its prevalence is 626, 900, and 833 per million inhabitants, and the percentage of patients with a functional graft is 10.3%, 1.8%, and 8.5%, with an annual number of transplants of 6.5, 0.8, and 8.7 per million inhabitants. Living donor transplants account for 99% of transplants in Algeria, 93% in Morocco, and 80% in Tunisia. In conclusion, access to transplantation remains low in the Maghreb countries, and all the modalities (living donor transplants, with an expanded donor pool, and deceased donor transplants) must be further developed. Recommendations have been issued to this end.
786	0		_nNéphrologie & Thérapeutique | Volume 20 | 1 | 2024-01-01 | p. 30-40 | 1769-7255
856	4	1	_uhttps://stm.cairn.info/journal-nephrologie-therapeutique-2024-1-page-30?lang=en&redirect-ssocas=7080
999			_c1613538 _d1613538